Francois Brisebois

Analyst

LifeSci Capital

Equibles does not estimate personal net worth.

About Francois Brisebois

Francois Brisebois is recorded as Analyst at LifeSci Capital. Francois Brisebois has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Opus Genetics, Inc. on September 9, 2026. Those appearances were for Opus Genetics, Inc. (IRD), Definium Therapeutics, Inc. (DFTX) and COMPASS Pathways plc (CMPS). The companies whose calls Francois Brisebois spoke on are classified in the Healthcare sector.

Francois Brisebois on recent calls

“So I was just wondering how, you know, in terms of picking, how confident are we that that is the right higher dose, just based on the fact that the vitelloform changes were probably, you know, exceeded expectations just on the fluid there.”

Analyst — LifeSci Capital, OPGx-BEST1 Cohort 1 Data Conference Call · September 9, 2026

“Maybe, thank you for that, and maybe if I could jump in quick with Matt. Matt, you made a comment there that you guys have shared before, but can you just help us understand, we don't hear this much, 1% penetration of the TAM equals to about 2 billion.”

Analyst — LifeSci Capital, Definium Therapeutics, Inc. Q1 FY2026 Earnings Call · June 22, 2026

“So just quickly here, in terms of the third quarter data for implications, could you just help us understand maybe what the expectations are and, you know, why, you know, is it still relegating factor to complete the filing based on the developments that have happened recently.”

Analyst — LifeSci Capital, COMPASS Pathways plc Q1 FY2026 Earnings Call · May 13, 2026